Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene
Klus Pharma Inc.
Klus Pharma Inc.
Ohio State University Comprehensive Cancer Center
Stanford University
National Institutes of Health Clinical Center (CC)
University Health Network, Toronto
Georgetown University
National Cancer Institute (NCI)